Cisapride can induce life-threatening torsades de pointes and QT prolongation even at relatively low doses and without other major interacting drugs.
Cautions clinicians regarding low-dose cisapride torsades risk even without major interactors; single case leaves open population incidence and mechanisms.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kim et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: